A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies
Clinical trial NCT04412577 · UNKNOWN
Trial details
- NCT number
- NCT04412577
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-12
- Primary completion
- 2021-12-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.